Goldman Sachs’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
137,587
-61,667
| -31% | -$187K | ﹤0.01% | 4353 |
|
|
2025
Q1 | $849K | Sell |
199,254
-3,971
| -2% | -$16.9K | ﹤0.01% | 3926 |
|
|
2024
Q4 | $1.07M | Buy |
+203,225
| New | +$1.07M | ﹤0.01% | 3876 |
|
|
2022
Q2 | – | Sell |
-152,847
| Closed | -$781K | – | 5849 |
|
|
2022
Q1 | $781K | Sell |
152,847
-44,455
| -23% | -$227K | ﹤0.01% | 4285 |
|
|
2021
Q4 | $1.33M | Buy |
197,302
+41,329
| +26% | +$279K | ﹤0.01% | 3811 |
|
|
2021
Q3 | $1.08M | Buy |
155,973
+23,716
| +18% | +$164K | ﹤0.01% | 3919 |
|
|
2021
Q2 | $1.29M | Buy |
+132,257
| New | +$1.29M | ﹤0.01% | 3840 |
|
|
2020
Q2 | – | Sell |
-15,299
| Closed | -$352K | – | 4548 |
|
|
2020
Q1 | $352K | Buy |
+15,299
| New | +$352K | ﹤0.01% | 3667 |
|